https://retacompare.com/news/study-links-glp-1-agonists-to-reduced-cancer-risk-in-nondiabetics 2026-10-30T18:22:36.000Z RetatrutideCompare en 2026-10-30T18:22:36.000Z Study Links GLP-1 Agonists to Reduced Cancer Risk in Nondiabetics Clinical Trials, Retatrutide https://retacompare.com/news/exploring-glp-1-agonists-link-to-breast-cancer-risks 2026-10-30T13:38:32.000Z RetatrutideCompare en 2026-10-30T13:38:32.000Z Exploring GLP-1 Agonists' Link to Breast Cancer Risks Market News, Retatrutide https://retacompare.com/news/retatrutide-shows-superior-results-to-ozempic-in-t2d-weight-loss-a1c-control 2026-10-30T10:00:37.000Z RetatrutideCompare en 2026-10-30T10:00:37.000Z Retatrutide Shows Superior Results to Ozempic in T2D Weight Loss, A1c Control Clinical Trials, Retatrutide https://retacompare.com/news/exploring-new-roles-for-glp-1-receptor-agonists-beyond-diabetes-management 2026-10-30T04:00:00.000Z RetatrutideCompare en 2026-10-30T04:00:00.000Z Exploring New Roles for GLP-1 Receptor Agonists Beyond Diabetes Management Clinical Trials, Retatrutide https://retacompare.com/news/retatrutide-emerges-as-a-potentially-powerful-weight-loss-drug 2026-10-30T03:13:00.000Z RetatrutideCompare en 2026-10-30T03:13:00.000Z Retatrutide Emerges as a Potentially Powerful Weight Loss Drug Weight Loss, Retatrutide https://retacompare.com/news/impact-of-glp-1-drugs-on-us-healthcare-and-public-health-explored 2026-10-29T23:51:59.000Z RetatrutideCompare en 2026-10-29T23:51:59.000Z Impact of GLP-1 Drugs on US Healthcare and Public Health Explored Market News, Retatrutide https://retacompare.com/news/eli-lilly-s-glp-1-sales-surge-boosts-financial-outlook 2026-10-29T19:31:00.000Z RetatrutideCompare en 2026-10-29T19:31:00.000Z Eli Lilly's GLP-1 Sales Surge Boosts Financial Outlook Market News, Retatrutide https://retacompare.com/news/potential-long-term-side-effects-of-glp-1-drugs-highlighted-by-doctor 2026-10-29T17:56:42.000Z RetatrutideCompare en 2026-10-29T17:56:42.000Z Potential Long-Term Side Effects of GLP-1 Drugs Highlighted by Doctor Weight Loss, Retatrutide https://retacompare.com/news/financial-implications-of-glp-1-agonists-in-metabolic-treatments 2026-10-29T14:37:29.000Z RetatrutideCompare en 2026-10-29T14:37:29.000Z Financial Implications of GLP-1 Agonists in Metabolic Treatments Market News, Retatrutide https://retacompare.com/news/oura-and-uc-san-diego-health-to-analyze-glp-1-impact-with-smart-ring-data 2026-10-29T12:00:00.000Z RetatrutideCompare en 2026-10-29T12:00:00.000Z Oura and UC San Diego Health to Analyze GLP-1 Impact with Smart Ring Data Patient Experiences, Retatrutide https://retacompare.com/news/retatrutide-outperforms-semaglutide-in-phase-3-a1c-and-weight-results 2026-10-29T06:33:45.000Z RetatrutideCompare en 2026-10-29T06:33:45.000Z Retatrutide Outperforms Semaglutide in Phase 3 A1C and Weight Results Clinical Trials, Retatrutide https://retacompare.com/news/eli-lilly-s-retatrutide-trial-news-affects-stock-valuation 2026-10-29T00:12:00.000Z RetatrutideCompare en 2026-10-29T00:12:00.000Z Eli Lilly's Retatrutide Trial News Affects Stock Valuation Market News, Retatrutide https://retacompare.com/news/digital-food-purchases-respond-to-glp-1-therapy-in-obesity-study 2026-10-29T00:00:00.000Z RetatrutideCompare en 2026-10-29T00:00:00.000Z Digital Food Purchases Respond to GLP-1 Therapy in Obesity Study Patient Experiences, Retatrutide https://retacompare.com/news/analysis-compares-adverse-events-of-semaglutide-and-tirzepatide 2026-10-29T00:00:00.000Z RetatrutideCompare en 2026-10-29T00:00:00.000Z Analysis Compares Adverse Events of Semaglutide and Tirzepatide Clinical Trials, Retatrutide https://retacompare.com/news/evaluating-obesity-medications-in-older-adults-using-geriatrics-5ms-framework 2026-10-29T00:00:00.000Z RetatrutideCompare en 2026-10-29T00:00:00.000Z Evaluating Obesity Medications in Older Adults Using Geriatrics 5Ms Framework Weight Loss, Retatrutide https://retacompare.com/news/comparative-cardiovascular-risk-of-semaglutide-in-cancer-survivors 2026-10-29T00:00:00.000Z RetatrutideCompare en 2026-10-29T00:00:00.000Z Comparative Cardiovascular Risk of Semaglutide in Cancer Survivors Clinical Trials, Retatrutide https://retacompare.com/news/retatrutide-compared-to-ozempic-in-weight-loss-study 2026-10-28T23:32:48.000Z RetatrutideCompare en 2026-10-28T23:32:48.000Z Retatrutide Compared to Ozempic in Weight Loss Study Weight Loss, Retatrutide https://retacompare.com/news/retatrutide-shows-superior-a1c-weight-loss-over-semaglutide-in-trial 2026-10-28T22:40:25.000Z RetatrutideCompare en 2026-10-28T22:40:25.000Z Retatrutide Shows Superior A1C, Weight Loss Over Semaglutide in Trial Clinical Trials, Retatrutide https://retacompare.com/news/retatrutide-shows-superior-weight-loss-in-diabetes-compared-to-ozempic-in-trial 2026-10-28T19:51:26.000Z RetatrutideCompare en 2026-10-28T19:51:26.000Z Retatrutide Shows Superior Weight Loss in Diabetes Compared to Ozempic in Trial Clinical Trials, Retatrutide